
### [NCIT:C7464](http://purl.obolibrary.org/obo/NCIT_C7464)
**Label:** Acute Leukemia of Ambiguous Lineage

**Subclasses:** [NCIT:C6923](http://purl.obolibrary.org/obo/NCIT_C6923) (Acute Bilineal Leukemia), [NCIT:C82212](http://purl.obolibrary.org/obo/NCIT_C82212) (Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified), [NCIT:C126111](http://purl.obolibrary.org/obo/NCIT_C126111) (Infant Acute Biphenotypic Leukemia), [NCIT:C82179](http://purl.obolibrary.org/obo/NCIT_C82179) (Mixed Phenotype Acute Leukemia), [NCIT:C82213](http://purl.obolibrary.org/obo/NCIT_C82213) (Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified), [NCIT:C126110](http://purl.obolibrary.org/obo/NCIT_C126110) (Infant Acute Undifferentiated Leukemia), [NCIT:C82203](http://purl.obolibrary.org/obo/NCIT_C82203) (Mixed Phenotype Acute Leukemia with t(v;11q23.3); KMT2A Rearranged), [NCIT:C4673](http://purl.obolibrary.org/obo/NCIT_C4673) (Acute Biphenotypic Leukemia), [NCIT:C82217](http://purl.obolibrary.org/obo/NCIT_C82217) (Natural Killer Cell Lymphoblastic Leukemia/Lymphoma), [NCIT:C9298](http://purl.obolibrary.org/obo/NCIT_C9298) (Acute Undifferentiated Leukemia), [NCIT:C82192](http://purl.obolibrary.org/obo/NCIT_C82192) (Mixed Phenotype Acute Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1), 

**Class expressions from DL-Learner:**

- Thing 52.89%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40260](http://purl.obolibrary.org/obo/NCIT_C40260) (Vaginal Adenosquamous Carcinoma))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C4026](http://purl.obolibrary.org/obo/NCIT_C4026) (Ovarian Mucinous Cystadenocarcinoma))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40259](http://purl.obolibrary.org/obo/NCIT_C40259) (Vaginal Villous Adenoma))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40258](http://purl.obolibrary.org/obo/NCIT_C40258) (Vaginal Tubulovillous Adenoma))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40257](http://purl.obolibrary.org/obo/NCIT_C40257) (Vaginal Tubular Adenoma))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40255](http://purl.obolibrary.org/obo/NCIT_C40255) (Vaginal Mullerian Papilloma))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40252](http://purl.obolibrary.org/obo/NCIT_C40252) (Vaginal Mucinous Adenocarcinoma))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40251](http://purl.obolibrary.org/obo/NCIT_C40251) (Vaginal Endometrioid Adenocarcinoma))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40248](http://purl.obolibrary.org/obo/NCIT_C40248) (Vaginal Warty Carcinoma))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40245](http://purl.obolibrary.org/obo/NCIT_C40245) (Vaginal Basaloid Carcinoma))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40243](http://purl.obolibrary.org/obo/NCIT_C40243) (Vaginal Keratinizing Squamous Cell Carcinoma))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40239](http://purl.obolibrary.org/obo/NCIT_C40239) (Cervical Melanoma))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40236](http://purl.obolibrary.org/obo/NCIT_C40236) (Cervical Wilms Tumor))) 39.20%


